Retatrutide 50mg

Ultra High-Potency Triple Agonist Peptide for Advanced Metabolic Research

Retatrutide 50mg is a high-purity, research-grade peptide formulation designed for advanced metabolic research applications. Known as LY3437943, Retatrutide is an investigational triple hormone receptor agonist that activates three important metabolic pathways: GIP (Glucose-Dependent Insulinotropic Polypeptide), GLP–1 (Glucagon-Like Peptide-1), and glucagon receptors. This unique three-receptor approach is being studied for its potential effects on body weight regulation, glucose metabolism, appetite control, and energy balance.

The 50mg formulation provides a larger quantity of peptide material intended for extended laboratory research protocols requiring high-purity peptide supply.

Product Highlights

• Peptide: Retatrutide (LY3437943)
• Strength: 50mg per vial
• Category: Triple GIP / GLP–1 / Glucagon Receptor Agonist
• Form: Lyophilized (freeze-dried) peptide powder
• Purity: Research-grade peptide formulation
• Research Focus: Metabolic pathways, obesity research, glucose regulation, and energy metabolism

What Is Retatrutide Made Of?

Retatrutide is a synthetic peptide molecule engineered to mimic and activate three naturally occurring hormone pathways involved in metabolism:

• GIP receptor activity — associated with glucose-dependent insulin signaling and metabolic regulation.
• GLP-1 receptor activity — associated with appetite regulation, satiety signaling, and glucose control.
• Glucagon receptor activity — involved in energy expenditure and fat metabolism pathways.

The molecule was designed with structural modifications intended to improve stability and maintain activity over an extended period.

What Is Retatrutide Studied For?

Retatrutide is being investigated in clinical research for potential applications involving:

• Weight management research
• Appetite regulation
• Glucose metabolism
• Insulin sensitivity
• Energy expenditure
• Fat metabolism
• Obesity–related metabolic conditions
• Type 2 diabetes research
• Cardiometabolic health studies

Clinical trials have evaluated Retatrutide for obesity and metabolic conditions, with ongoing research exploring its long-term safety and effectiveness.

Potential Research Benefits

• Investigates multiple metabolic hormone pathways simultaneously
• Supports obesity and metabolic research studies
• Helps researchers study appetite and satiety signaling
• Provides insight into glucose regulation mechanisms
• Supports investigation of energy balance and body composition
• High-purity peptide format for laboratory research

How Retatrutide Works

Retatrutide combines three mechanisms into one peptide:

GLP-1 Pathway

Research focuses on GLP–1 activity involved in:

• Appetite signaling
• Satiety response
• Gastric emptying regulation
• Glucose-dependent insulin release

GIP Pathway

Research focuses on GIP activity involved in:

• Insulin regulation
• Nutrient metabolism
• Hormonal signaling

Glucagon Pathway

Research focuses on glucagon activity involved in:

• Energy expenditure
• Metabolic rate regulation
• Fat utilization pathways

The combination of these three pathways makes Retatrutide different from single- or dual-pathway metabolic peptides currently being studied.

Storage Information

• Store unopened lyophilized peptide in a cool, dry environment.
• Protect from heat, moisture, and direct light.
• Follow manufacturer storage recommendations.
• Handle only according to appropriate laboratory procedures.

Batch R50725 • 99%+ Purity Guaranteed • Ships Today